Global Real World Evidence Analytics Market

Real World Evidence Analytics Market Size, Share, Growth Analysis, By End user(Pharmaceutical, Biotechnology, Medical Device Companies, Healthcare Payers), By Application(Market Access & Reimbursement, Drug Development & Approval, Post Market Surveillance, Medical Device Development), By Therapeutic Area(Oncology, Cardiovascular, Neurology, Immunology), By Region - Industry Forecast 2024-2031

Report ID: SQSG35G2031 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 95 | Figures: 76

Real World Evidence Analytics Market News

  • In October 2022, Nextdoor announced a strategic collaboration with Oracle Advertising that will offer greater transparency and controls to Nextdoor advertisers, helping ensure high-value, optimal ad experiences on the platform.
  • In September 2022, Walmart and UnitedHealth Group Collaborate To Deliver Access to High-Quality, Affordable Health Care.
  • In December 2021, A proposed all-cash acquisition of Clinigen, which values the pharmaceutical company at £1.2bn, has been recommended to shareholders.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Real World Evidence Analytics Market size was valued at USD 2.26 billion in 2019 and is poised to grow from USD 2.45 billion in 2023 to USD 4.97 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031).

Global Real World Evidence Analytics Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'IQVIA Inc.', 'Optum, Inc.', 'IBM Corporation', 'Parexel International Corporation', 'Cognizant Technology Solutions Corporation', 'Oracle Corporation', 'Clinigen Group PLC', 'SAS Institute Inc.', 'PPD, Inc.', 'Syneos Health, Inc.', 'Anthem, Inc.', 'Change Healthcare Inc.', 'Pharmaceutical Product Development, LLC (PPD)', 'Evidera, Inc.', 'ICON plc', 'Flatiron Health, Inc.', 'HealthVerity, Inc.', 'PAREXEL International Corporation', 'Phesi Inc.', 'Aetion, Inc.'

Rising Geriatric Population to Drive Market Growth

Introduction of AI to Surge Market Growth

North America dominated the market in 2021. Some of the key factors anticipated to propel the growth of this market include the rising prevalence of chronic diseases in the elderly population, a move toward value-based care, an increase in personalised healthcare, the availability of electronic datasets, a well-established healthcare industry, and the growth of big data in the healthcare sector.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Real World Evidence Solutions Market
Buy Now GET FREE SAMPLE
Document Analytics Market
Buy Now GET FREE SAMPLE
Data Analytics Market
Buy Now GET FREE SAMPLE
Risk Analytics Market
Buy Now GET FREE SAMPLE
CRM Analytics Market
Buy Now GET FREE SAMPLE
Social Media Analytics Market
Buy Now GET FREE SAMPLE
Predictive Analytics Market
Buy Now GET FREE SAMPLE
Advanced Analytics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Real World Evidence Analytics Market

Report ID: SQSG35G2031

$5,300
BUY NOW GET FREE SAMPLE